Albireo Pharma (NASDAQ:ALBO) initiated with Buy rating and $35 price target by Needham.
Acadia Healthcare (NASDAQ:ACHC) initiated with Outperform rating by William Blair.
Heron Therapeutics (NASDAQ:HRTX) initiated with Buy rating by Aegis Capital.
Inovio Pharmaceuticals (NYSEMKT:INO) initiated with Buy rating by Aegis.
Aduro Biotech (NASDAQ:ADRO) initiated with Outperform rating by Cowen.
Impax Labs (NASDAQ:IPXL) upgraded to Neutral from Underweight by Piper Jaffray.
Quidel (NASDAQ:QDEL) upgraded to Buy from Hold with a $42 price target by Canaccord Genuity. Upgraded to Outperform by William Blair.
Intuitive Surgical (NASDAQ:ISRG) price target raised to $950 from $800 by RBC Capital Markets on expectations of Q2 beat and higher procedure growth guidance.Maintains Sector Perform rating.
Paratek Pharma (NASDAQ:PRTK) price target raised to $43 from $36 by H.C. Wainwright after positive OASIS-2 data.